Phreesia price target lowered to $28 from $36 at Mizuho

Mizuho analyst Steven Valiquette lowered the firm’s price target on Phreesia (PHR) to $28 from $36 and keeps an Outperform rating on the shares. Shares fell 22% after management struck a more cautious tone on Q4 Network Solutions revenue, citing softer Pharma digital marketing sentiment amid political pressures, the analyst tells investors in a research note. While FY27 growth may slow to roughly the low-teens, management’s outlook appears conservative, Mizuho adds.